Table of Content

1 Report Overview
1.1 Veterinary Biologics Definition
1.2 Market by Type
1.2.1 Global Veterinary Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Vaccines
1.2.3 Monoclonal Antibodies
1.3 Market Segment by Application
1.3.1 Global Veterinary Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Llivestock
1.3.3 Equine
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Veterinary Biologics Sales
2.1 Global Veterinary Biologics Revenue Estimates and Forecasts 2018-2034
2.2 Global Veterinary Biologics Revenue by Region: 2018 VS 2022 VS 2034
2.3 Global Veterinary Biologics Revenue by Region
2.3.1 Global Veterinary Biologics Revenue by Region (2018-2024)
2.3.2 Global Veterinary Biologics Revenue by Region (2024-2034)
2.4 Global Veterinary Biologics Sales Quantity Estimates and Forecasts 2018-2034
2.5 Global Veterinary Biologics Sales Quantity by Region: 2018 VS 2022 VS 2034
2.6 Global Veterinary Biologics Sales Quantity by Region
2.6.1 Global Veterinary Biologics Sales Quantity by Region (2018-2024)
2.6.2 Global Veterinary Biologics Sales Quantity by Region (2024-2034)
2.7 North America
2.8 Europe
2.9 China
2.10 APAC (excluding China)
2.11 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Veterinary Biologics Sales Quantity by Manufacturers
3.1.1 Global Veterinary Biologics Sales Quantity by Manufacturers (2018-2024)
3.1.2 Global Veterinary Biologics Sales Quantity Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Companies by Veterinary Biologics Sales in 2022
3.2 Global Veterinary Biologics Revenue by Manufacturers
3.2.1 Global Veterinary Biologics Revenue by Manufacturers (2018-2024)
3.2.2 Global Veterinary Biologics Revenue Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Veterinary Biologics Revenue in 2022
3.3 Global Veterinary Biologics Sales Price by Manufacturers
3.4 Global Key Players of Veterinary Biologics, Industry Ranking, 2021 VS 2022
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Veterinary Biologics, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Veterinary Biologics, Product Offered and Application
3.8 Global Key Manufacturers of Veterinary Biologics, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Estimates and Forecasts by Type
4.1 Global Veterinary Biologics Sales Quantity by Type
4.1.1 Global Veterinary Biologics Historical Sales Quantity by Type (2018-2024)
4.1.2 Global Veterinary Biologics Forecasted Sales Quantity by Type (2024-2034)
4.1.3 Global Veterinary Biologics Sales Quantity Market Share by Type (2018-2034)
4.2 Global Veterinary Biologics Revenue by Type
4.2.1 Global Veterinary Biologics Historical Revenue by Type (2018-2024)
4.2.2 Global Veterinary Biologics Forecasted Revenue by Type (2024-2034)
4.2.3 Global Veterinary Biologics Revenue Market Share by Type (2018-2034)
4.3 Global Veterinary Biologics Price by Type
4.3.1 Global Veterinary Biologics Price by Type (2018-2024)
4.3.2 Global Veterinary Biologics Price Forecast by Type (2024-2034)
5 Market Size by Application
5.1 Global Veterinary Biologics Sales Quantity by Application
5.1.1 Global Veterinary Biologics Historical Sales Quantity by Application (2018-2024)
5.1.2 Global Veterinary Biologics Forecasted Sales Quantity by Application (2024-2034)
5.1.3 Global Veterinary Biologics Sales Quantity Market Share by Application (2018-2034)
5.2 Global Veterinary Biologics Revenue by Application
5.2.1 Global Veterinary Biologics Historical Revenue by Application (2018-2024)
5.2.2 Global Veterinary Biologics Forecasted Revenue by Application (2024-2034)
5.2.3 Global Veterinary Biologics Revenue Market Share by Application (2018-2034)
5.3 Global Veterinary Biologics Price by Application
5.3.1 Global Veterinary Biologics Price by Application (2018-2024)
5.3.2 Global Veterinary Biologics Price Forecast by Application (2024-2034)
6 North America
6.1 North America Veterinary Biologics Sales by Company
6.1.1 North America Veterinary Biologics Revenue by Company (2018-2024)
6.1.2 North America Veterinary Biologics Sales Quantity by Company (2018-2024)
6.2 North America Veterinary Biologics Market Size by Type
6.2.1 North America Veterinary Biologics Sales Quantity by Type (2018-2034)
6.2.2 North America Veterinary Biologics Revenue by Type (2018-2034)
6.3 North America Veterinary Biologics Market Size by Application
6.3.1 North America Veterinary Biologics Sales Quantity by Application (2018-2034)
6.3.2 North America Veterinary Biologics Revenue by Application (2018-2034)
6.4 North America Veterinary Biologics Market Size by Country
6.4.1 North America Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2034
6.4.2 North America Veterinary Biologics Revenue by Country (2018-2034)
6.4.3 North America Veterinary Biologics Sales Quantity by Country (2018-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Veterinary Biologics Sales by Company
7.1.1 Europe Veterinary Biologics Sales Quantity by Company (2018-2024)
7.1.2 Europe Veterinary Biologics Revenue by Company (2018-2024)
7.2 Europe Veterinary Biologics Market Size by Type
7.2.1 Europe Veterinary Biologics Sales Quantity by Type (2018-2034)
7.2.2 Europe Veterinary Biologics Revenue by Type (2018-2034)
7.3 Europe Veterinary Biologics Market Size by Application
7.3.1 Europe Veterinary Biologics Sales Quantity by Application (2018-2034)
7.3.2 Europe Veterinary Biologics Revenue by Application (2018-2034)
7.4 Europe Veterinary Biologics Market Size by Country
7.4.1 Europe Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Veterinary Biologics Revenue by Country (2018-2034)
7.4.3 Europe Veterinary Biologics Sales Quantity by Country (2018-2034)
7.4.4 Germany
7.4.5 France
7.4.6 U.K.
7.4.7 Italy
7.4.8 Russia
8 China
8.1 China Veterinary Biologics Sales by Company
8.1.1 China Veterinary Biologics Sales Quantity by Company (2018-2024)
8.1.2 China Veterinary Biologics Revenue by Company (2018-2024)
8.2 China Veterinary Biologics Market Size by Type
8.2.1 China Veterinary Biologics Sales Quantity by Type (2018-2034)
8.2.2 China Veterinary Biologics Revenue by Type (2018-2034)
8.3 China Veterinary Biologics Market Size by Application
8.3.1 China Veterinary Biologics Sales Quantity by Application (2018-2034)
8.3.2 China Veterinary Biologics Revenue by Application (2018-2034)
9 APAC (excluding China)
9.1 APAC Veterinary Biologics Sales by Company
9.1.1 APAC Veterinary Biologics Sales Quantity by Company (2018-2024)
9.1.2 APAC Veterinary Biologics Revenue by Company (2018-2024)
9.2 APAC Veterinary Biologics Market Size by Type
9.2.1 APAC Veterinary Biologics Sales Quantity by Type (2018-2034)
9.2.2 APAC Veterinary Biologics Revenue by Type (2018-2034)
9.3 APAC Veterinary Biologics Market Size by Application
9.3.1 APAC Veterinary Biologics Sales Quantity by Application (2018-2034)
9.3.2 APAC Veterinary Biologics Revenue by Application (2018-2034)
9.4 APAC Veterinary Biologics Market Size by Region
9.4.1 APAC Veterinary Biologics Revenue by Region: 2018 VS 2022 VS 2034
9.4.2 APAC Veterinary Biologics Revenue by Region (2018-2034)
9.4.3 APAC Veterinary Biologics Sales Quantity by Region (2018-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Veterinary Biologics Sales by Company
10.1.1 Middle East, Africa and Latin America Veterinary Biologics Sales Quantity by Company (2018-2024)
10.1.2 Middle East, Africa and Latin America Veterinary Biologics Revenue by Company (2018-2024)
10.2 Middle East, Africa and Latin America Veterinary Biologics Market Size by Type
10.2.1 Middle East, Africa and Latin America Veterinary Biologics Sales Quantity by Type (2018-2034)
10.2.2 Middle East, Africa and Latin America Veterinary Biologics Revenue by Type (2018-2034)
10.3 Middle East, Africa and Latin America Veterinary Biologics Market Size by Application
10.3.1 Middle East, Africa and Latin America Veterinary Biologics Sales Quantity by Application (2018-2034)
10.3.2 Middle East, Africa and Latin America Veterinary Biologics Revenue by Application (2018-2034)
10.4 Middle East, Africa and Latin America Veterinary Biologics Market Size by Country
10.4.1 Middle East, Africa and Latin America Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa and Latin America Veterinary Biologics Revenue by Country (2018-2034)
10.4.3 Middle East, Africa and Latin America Veterinary Biologics Sales Quantity by Country (2018-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Israel
10.4.8 GCC Countries
11 Company Profiles
11.1 Merck
11.1.1 Merck Company Information
11.1.2 Merck Overview
11.1.3 Merck Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.1.4 Merck Veterinary Biologics Products and Services
11.1.5 Merck Veterinary Biologics SWOT Analysis
11.1.6 Merck Recent Developments
11.2 Zoetis
11.2.1 Zoetis Company Information
11.2.2 Zoetis Overview
11.2.3 Zoetis Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.2.4 Zoetis Veterinary Biologics Products and Services
11.2.5 Zoetis Veterinary Biologics SWOT Analysis
11.2.6 Zoetis Recent Developments
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Information
11.3.2 Boehringer Ingelheim Overview
11.3.3 Boehringer Ingelheim Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.3.4 Boehringer Ingelheim Veterinary Biologics Products and Services
11.3.5 Boehringer Ingelheim Veterinary Biologics SWOT Analysis
11.3.6 Boehringer Ingelheim Recent Developments
11.4 Ceva
11.4.1 Ceva Company Information
11.4.2 Ceva Overview
11.4.3 Ceva Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.4.4 Ceva Veterinary Biologics Products and Services
11.4.5 Ceva Veterinary Biologics SWOT Analysis
11.4.6 Ceva Recent Developments
11.5 CAHIC
11.5.1 CAHIC Company Information
11.5.2 CAHIC Overview
11.5.3 CAHIC Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.5.4 CAHIC Veterinary Biologics Products and Services
11.5.5 CAHIC Veterinary Biologics SWOT Analysis
11.5.6 CAHIC Recent Developments
11.6 HVRI
11.6.1 HVRI Company Information
11.6.2 HVRI Overview
11.6.3 HVRI Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.6.4 HVRI Veterinary Biologics Products and Services
11.6.5 HVRI Veterinary Biologics SWOT Analysis
11.6.6 HVRI Recent Developments
11.7 Ringpu Biology
11.7.1 Ringpu Biology Company Information
11.7.2 Ringpu Biology Overview
11.7.3 Ringpu Biology Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.7.4 Ringpu Biology Veterinary Biologics Products and Services
11.7.5 Ringpu Biology Veterinary Biologics SWOT Analysis
11.7.6 Ringpu Biology Recent Developments
11.8 Yebio
11.8.1 Yebio Company Information
11.8.2 Yebio Overview
11.8.3 Yebio Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.8.4 Yebio Veterinary Biologics Products and Services
11.8.5 Yebio Veterinary Biologics SWOT Analysis
11.8.6 Yebio Recent Developments
11.9 DHN
11.9.1 DHN Company Information
11.9.2 DHN Overview
11.9.3 DHN Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.9.4 DHN Veterinary Biologics Products and Services
11.9.5 DHN Veterinary Biologics SWOT Analysis
11.9.6 DHN Recent Developments
11.10 WINSUN
11.10.1 WINSUN Company Information
11.10.2 WINSUN Overview
11.10.3 WINSUN Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.10.4 WINSUN Veterinary Biologics Products and Services
11.10.5 WINSUN Veterinary Biologics SWOT Analysis
11.10.6 WINSUN Recent Developments
11.11 Elanco/Eli Lilly
11.11.1 Elanco/Eli Lilly Company Information
11.11.2 Elanco/Eli Lilly Overview
11.11.3 Elanco/Eli Lilly Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.11.4 Elanco/Eli Lilly Veterinary Biologics Products and Services
11.11.5 Elanco/Eli Lilly Recent Developments
11.12 Virbac
11.12.1 Virbac Company Information
11.12.2 Virbac Overview
11.12.3 Virbac Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.12.4 Virbac Veterinary Biologics Products and Services
11.12.5 Virbac Recent Developments
11.13 Jinyu Bio-Technology
11.13.1 Jinyu Bio-Technology Company Information
11.13.2 Jinyu Bio-Technology Overview
11.13.3 Jinyu Bio-Technology Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.13.4 Jinyu Bio-Technology Veterinary Biologics Products and Services
11.13.5 Jinyu Bio-Technology Recent Developments
11.14 ChengDu Tecbond
11.14.1 ChengDu Tecbond Company Information
11.14.2 ChengDu Tecbond Overview
11.14.3 ChengDu Tecbond Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.14.4 ChengDu Tecbond Veterinary Biologics Products and Services
11.14.5 ChengDu Tecbond Recent Developments
11.15 CAVAC
11.15.1 CAVAC Company Information
11.15.2 CAVAC Overview
11.15.3 CAVAC Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.15.4 CAVAC Veterinary Biologics Products and Services
11.15.5 CAVAC Recent Developments
11.16 Kyoto Biken
11.16.1 Kyoto Biken Company Information
11.16.2 Kyoto Biken Overview
11.16.3 Kyoto Biken Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.16.4 Kyoto Biken Veterinary Biologics Products and Services
11.16.5 Kyoto Biken Recent Developments
11.17 FATRO
11.17.1 FATRO Company Information
11.17.2 FATRO Overview
11.17.3 FATRO Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.17.4 FATRO Veterinary Biologics Products and Services
11.17.5 FATRO Recent Developments
11.18 Vaksindo
11.18.1 Vaksindo Company Information
11.18.2 Vaksindo Overview
11.18.3 Vaksindo Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.18.4 Vaksindo Veterinary Biologics Products and Services
11.18.5 Vaksindo Recent Developments
11.19 Bio-Labs
11.19.1 Bio-Labs Company Information
11.19.2 Bio-Labs Overview
11.19.3 Bio-Labs Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.19.4 Bio-Labs Veterinary Biologics Products and Services
11.19.5 Bio-Labs Recent Developments
11.20 Avimex Animal
11.20.1 Avimex Animal Company Information
11.20.2 Avimex Animal Overview
11.20.3 Avimex Animal Veterinary Biologics Sales Quantity, Revenue, Average Selling Price (ASP) and Gross Margin (2018-2024)
11.20.4 Avimex Animal Veterinary Biologics Products and Services
11.20.5 Avimex Animal Recent Developments
12 Value Chain and Sales Channels Analysis
12.1 Veterinary Biologics Value Chain Analysis
12.2 Veterinary Biologics Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Veterinary Biologics Production Mode & Process
12.4 Veterinary Biologics Sales and Marketing
12.4.1 Veterinary Biologics Sales Channels
12.4.2 Veterinary Biologics Distributors
12.5 Veterinary Biologics Customers
13 Market Dynamics
13.1 Veterinary Biologics Industry Trends
13.2 Veterinary Biologics Market Drivers
13.3 Veterinary Biologics Market Challenges
13.4 Veterinary Biologics Market Restraints
14 Key Findings
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Veterinary Biologics Market Size Growth Rate (CAGR) by Type, 2018 VS 2022 VS 2034 (US$ Million)
Table 2. Major Manufacturers of Vaccines
Table 3. Major Manufacturers of Monoclonal Antibodies
Table 4. Global Veterinary Biologics Market Size Growth Rate (CAGR) by Application, 2018 VS 2022 VS 2034 (US$ Million)
Table 5. Global Veterinary Biologics Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 6. Global Veterinary Biologics Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Veterinary Biologics Revenue Market Share by Region (2018-2024)
Table 8. Global Veterinary Biologics Revenue by Region (2024-2034) & (US$ Million)
Table 9. Global Veterinary Biologics Revenue Market Share by Region (2024-2034)
Table 10. Global Veterinary Biologics Sales Quantity by Region: 2018 VS 2022 VS 2034 (K Units)
Table 11. Global Veterinary Biologics Sales by Region (2018-2024) & (K Units)
Table 12. Global Veterinary Biologics Sales Market Share by Region (2018-2024)
Table 13. Global Veterinary Biologics Sales by Region (2024-2034) & (K Units)
Table 14. Global Veterinary Biologics Sales Market Share by Region (2024-2034)
Table 15. Global Veterinary Biologics Sales Quantity by Manufacturers (2018-2024) & (K Units)
Table 16. Global Veterinary Biologics Sales Quantity Share by Manufacturers (2018-2024)
Table 17. Global Veterinary Biologics Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Veterinary Biologics Revenue Share by Manufacturers (2018-2024)
Table 19. Global Veterinary Biologics Price by Manufacturers 2018-2024 (US$/Unit)
Table 20. Global Key Players of Veterinary Biologics, Industry Ranking, 2021 VS 2022
Table 21. Global Veterinary Biologics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Veterinary Biologics by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Veterinary Biologics as of 2022)
Table 23. Global Key Manufacturers of Veterinary Biologics, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Veterinary Biologics, Product Offered and Application
Table 25. Global Key Manufacturers of Veterinary Biologics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Veterinary Biologics Sales Quantity by Type (2018-2024) & (K Units)
Table 28. Global Veterinary Biologics Sales Quantity by Type (2024-2034) & (K Units)
Table 29. Global Veterinary Biologics Sales Quantity Share by Type (2018-2024)
Table 30. Global Veterinary Biologics Sales Quantity Share by Type (2024-2034)
Table 31. Global Veterinary Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Veterinary Biologics Revenue by Type (2024-2034) & (US$ Million)
Table 33. Global Veterinary Biologics Revenue Share by Type (2018-2024)
Table 34. Global Veterinary Biologics Revenue Share by Type (2024-2034)
Table 35. Veterinary Biologics Price by Type (2018-2024) & (US$/Unit)
Table 36. Global Veterinary Biologics Price Forecast by Type (2024-2034) & (US$/Unit)
Table 37. Global Veterinary Biologics Sales Quantity by Application (2018-2024) & (K Units)
Table 38. Global Veterinary Biologics Sales Quantity by Application (2024-2034) & (K Units)
Table 39. Global Veterinary Biologics Sales Quantity Share by Application (2018-2024)
Table 40. Global Veterinary Biologics Sales Quantity Share by Application (2024-2034)
Table 41. Global Veterinary Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Veterinary Biologics Revenue by Application (2024-2034) & (US$ Million)
Table 43. Global Veterinary Biologics Revenue Share by Application (2018-2024)
Table 44. Global Veterinary Biologics Revenue Share by Application (2024-2034)
Table 45. Veterinary Biologics Price by Application (2018-2024) & (US$/Unit)
Table 46. Global Veterinary Biologics Price Forecast by Application (2024-2034) & (US$/Unit)
Table 47. North America Veterinary Biologics Revenue by Company (2018-2024) & (US$ Million)
Table 48. North America Veterinary Biologics Sales Quantity by Company (2018-2024) & (K Units)
Table 49. North America Veterinary Biologics Sales Quantity by Type (2018-2024) & (K Units)
Table 50. North America Veterinary Biologics Sales Quantity by Type (2024-2034) & (K Units)
Table 51. North America Veterinary Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 52. North America Veterinary Biologics Revenue by Type (2024-2034) & (US$ Million)
Table 53. North America Veterinary Biologics Sales Quantity by Application (2018-2024) & (K Units)
Table 54. North America Veterinary Biologics Sales Quantity by Application (2024-2034) & (K Units)
Table 55. North America Veterinary Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 56. North America Veterinary Biologics Revenue by Application (2024-2034) & (US$ Million)
Table 57. North America Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 58. North America Veterinary Biologics Revenue by Country (2018-2024) & (US$ Million)
Table 59. North America Veterinary Biologics Revenue by Country (2024-2034) & (US$ Million)
Table 60. North America Veterinary Biologics Sales Quantity by Country (2018-2024) & (K Units)
Table 61. North America Veterinary Biologics Sales Quantity by Country (2024-2034) & (K Units)
Table 62. Europe Veterinary Biologics Sales Quantity by Company (2018-2024) & (K Units)
Table 63. Europe Veterinary Biologics Revenue by Company (2018-2024) & (US$ Million)
Table 64. Europe Veterinary Biologics Sales Quantity by Type (2018-2024) & (K Units)
Table 65. Europe Veterinary Biologics Sales Quantity by Type (2024-2034) & (K Units)
Table 66. Europe Veterinary Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 67. Europe Veterinary Biologics Revenue by Type (2024-2034) & (US$ Million)
Table 68. Europe Veterinary Biologics Sales Quantity by Application (2018-2024) & (K Units)
Table 69. Europe Veterinary Biologics Sales Quantity by Application (2024-2034) & (K Units)
Table 70. Europe Veterinary Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 71. Europe Veterinary Biologics Revenue by Application (2024-2034) & (US$ Million)
Table 72. Europe Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 73. Europe Veterinary Biologics Revenue by Country (2018-2024) & (US$ Million)
Table 74. Europe Veterinary Biologics Revenue by Country (2024-2034) & (US$ Million)
Table 75. Europe Veterinary Biologics Sales Quantity by Country (2018-2024) & (K Units)
Table 76. Europe Veterinary Biologics Sales Quantity by Country (2024-2034) & (K Units)
Table 77. China Veterinary Biologics Sales Quantity by Company (2018-2024) & (K Units)
Table 78. China Veterinary Biologics Revenue by Company (2018-2024) & (US$ Million)
Table 79. China Veterinary Biologics Sales Quantity by Type (2018-2024) & (K Units)
Table 80. China Veterinary Biologics Sales Quantity by Type (2024-2034) & (K Units)
Table 81. China Veterinary Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 82. China Veterinary Biologics Revenue by Type (2024-2034) & (US$ Million)
Table 83. China Veterinary Biologics Sales Quantity by Application (2018-2024) & (K Units)
Table 84. China Veterinary Biologics Sales Quantity by Application (2024-2034) & (K Units)
Table 85. China Veterinary Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 86. China Veterinary Biologics Revenue by Application (2024-2034) & (US$ Million)
Table 87. APAC Veterinary Biologics Sales Quantity by Company (2018-2024) & (K Units)
Table 88. APAC Veterinary Biologics Revenue by Company (2018-2024) & (US$ Million)
Table 89. APAC Veterinary Biologics Sales Quantity by Type (2018-2024) & (K Units)
Table 90. APAC Veterinary Biologics Sales Quantity by Type (2024-2034) & (K Units)
Table 91. APAC Veterinary Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 92. APAC Veterinary Biologics Revenue by Type (2024-2034) & (US$ Million)
Table 93. APAC Veterinary Biologics Sales Quantity by Application (2018-2024) & (K Units)
Table 94. APAC Veterinary Biologics Sales Quantity by Application (2024-2034) & (K Units)
Table 95. APAC Veterinary Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 96. APAC Veterinary Biologics Revenue by Application (2024-2034) & (US$ Million)
Table 97. APAC Veterinary Biologics Revenue by Region: 2018 VS 2022 VS 2034 (US$ Million)
Table 98. APAC Veterinary Biologics Revenue by Region (2018-2024) & (US$ Million)
Table 99. APAC Veterinary Biologics Revenue by Region (2024-2034) & (US$ Million)
Table 100. APAC Veterinary Biologics Sales Quantity by Region (2018-2024) & (K Units)
Table 101. APAC Veterinary Biologics Sales Quantity by Region (2024-2034) & (K Units)
Table 102. Middle East, Africa and Latin America Veterinary Biologics Sales Quantity by Company (2018-2024) & (K Units)
Table 103. Middle East, Africa and Latin America Veterinary Biologics Revenue by Company (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Veterinary Biologics Sales Quantity by Type (2018-2024) & (K Units)
Table 105. Middle East, Africa and Latin America Veterinary Biologics Sales Quantity by Type (2024-2034) & (K Units)
Table 106. Middle East, Africa and Latin America Veterinary Biologics Revenue by Type (2018-2024) & (US$ Million)
Table 107. Middle East, Africa and Latin America Veterinary Biologics Revenue by Type (2024-2034) & (US$ Million)
Table 108. Middle East, Africa and Latin America Veterinary Biologics Sales Quantity by Application (2018-2024) & (K Units)
Table 109. Middle East, Africa and Latin America Veterinary Biologics Sales Quantity by Application (2024-2034) & (K Units)
Table 110. Middle East, Africa and Latin America Veterinary Biologics Revenue by Application (2018-2024) & (US$ Million)
Table 111. Middle East, Africa and Latin America Veterinary Biologics Revenue by Application (2024-2034) & (US$ Million)
Table 112. Middle East, Africa and Latin America Veterinary Biologics Revenue by Country: 2018 VS 2022 VS 2034 (US$ Million)
Table 113. Middle East, Africa and Latin America Veterinary Biologics Revenue by Country (2018-2024) & (US$ Million)
Table 114. Middle East, Africa and Latin America Veterinary Biologics Revenue by Country (2024-2034) & (US$ Million)
Table 115. Middle East, Africa and Latin America Veterinary Biologics Sales Quantity by Country (2018-2024) & (K Units)
Table 116. Middle East, Africa and Latin America Veterinary Biologics Sales Quantity by Country (2024-2034) & (K Units)
Table 117. Merck Company Information
Table 118. Merck Description and Overview
Table 119. Merck Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 120. Merck Veterinary Biologics Product and Services
Table 121. Merck Veterinary Biologics SWOT Analysis
Table 122. Merck Recent Developments
Table 123. Zoetis Company Information
Table 124. Zoetis Description and Overview
Table 125. Zoetis Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 126. Zoetis Veterinary Biologics Product and Services
Table 127. Zoetis Veterinary Biologics SWOT Analysis
Table 128. Zoetis Recent Developments
Table 129. Boehringer Ingelheim Company Information
Table 130. Boehringer Ingelheim Description and Overview
Table 131. Boehringer Ingelheim Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 132. Boehringer Ingelheim Veterinary Biologics Product and Services
Table 133. Boehringer Ingelheim Veterinary Biologics SWOT Analysis
Table 134. Boehringer Ingelheim Recent Developments
Table 135. Ceva Company Information
Table 136. Ceva Description and Overview
Table 137. Ceva Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 138. Ceva Veterinary Biologics Product and Services
Table 139. Ceva Veterinary Biologics SWOT Analysis
Table 140. Ceva Recent Developments
Table 141. CAHIC Company Information
Table 142. CAHIC Description and Overview
Table 143. CAHIC Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 144. CAHIC Veterinary Biologics Product and Services
Table 145. CAHIC Veterinary Biologics SWOT Analysis
Table 146. CAHIC Recent Developments
Table 147. HVRI Company Information
Table 148. HVRI Description and Overview
Table 149. HVRI Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 150. HVRI Veterinary Biologics Product and Services
Table 151. HVRI Veterinary Biologics SWOT Analysis
Table 152. HVRI Recent Developments
Table 153. Ringpu Biology Company Information
Table 154. Ringpu Biology Description and Overview
Table 155. Ringpu Biology Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 156. Ringpu Biology Veterinary Biologics Product and Services
Table 157. Ringpu Biology Veterinary Biologics SWOT Analysis
Table 158. Ringpu Biology Recent Developments
Table 159. Yebio Company Information
Table 160. Yebio Description and Overview
Table 161. Yebio Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 162. Yebio Veterinary Biologics Product and Services
Table 163. Yebio Veterinary Biologics SWOT Analysis
Table 164. Yebio Recent Developments
Table 165. DHN Company Information
Table 166. DHN Description and Overview
Table 167. DHN Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 168. DHN Veterinary Biologics Product and Services
Table 169. DHN Veterinary Biologics SWOT Analysis
Table 170. DHN Recent Developments
Table 171. WINSUN Company Information
Table 172. WINSUN Description and Overview
Table 173. WINSUN Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 174. WINSUN Veterinary Biologics Product and Services
Table 175. WINSUN Veterinary Biologics SWOT Analysis
Table 176. WINSUN Recent Developments
Table 177. Elanco/Eli Lilly Company Information
Table 178. Elanco/Eli Lilly Description and Overview
Table 179. Elanco/Eli Lilly Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 180. Elanco/Eli Lilly Veterinary Biologics Product and Services
Table 181. Elanco/Eli Lilly Recent Developments
Table 182. Virbac Company Information
Table 183. Virbac Description and Overview
Table 184. Virbac Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 185. Virbac Veterinary Biologics Product and Services
Table 186. Virbac Recent Developments
Table 187. Jinyu Bio-Technology Company Information
Table 188. Jinyu Bio-Technology Description and Overview
Table 189. Jinyu Bio-Technology Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 190. Jinyu Bio-Technology Veterinary Biologics Product and Services
Table 191. Jinyu Bio-Technology Recent Developments
Table 192. ChengDu Tecbond Company Information
Table 193. ChengDu Tecbond Description and Overview
Table 194. ChengDu Tecbond Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 195. ChengDu Tecbond Veterinary Biologics Product and Services
Table 196. ChengDu Tecbond Recent Developments
Table 197. CAVAC Company Information
Table 198. CAVAC Description and Overview
Table 199. CAVAC Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 200. CAVAC Veterinary Biologics Product and Services
Table 201. CAVAC Recent Developments
Table 202. Kyoto Biken Company Information
Table 203. Kyoto Biken Description and Overview
Table 204. Kyoto Biken Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 205. Kyoto Biken Veterinary Biologics Product and Services
Table 206. Kyoto Biken Recent Developments
Table 207. FATRO Company Information
Table 208. FATRO Description and Overview
Table 209. FATRO Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 210. FATRO Veterinary Biologics Product and Services
Table 211. FATRO Recent Developments
Table 212. Vaksindo Company Information
Table 213. Vaksindo Description and Overview
Table 214. Vaksindo Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 215. Vaksindo Veterinary Biologics Product and Services
Table 216. Vaksindo Recent Developments
Table 217. Bio-Labs Company Information
Table 218. Bio-Labs Description and Overview
Table 219. Bio-Labs Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 220. Bio-Labs Veterinary Biologics Product and Services
Table 221. Bio-Labs Recent Developments
Table 222. Avimex Animal Company Information
Table 223. Avimex Animal Description and Overview
Table 224. Avimex Animal Veterinary Biologics Sales Quantity (K Units), Revenue (US$ Million), Average Selling Price (ASP) (US$/Unit) and Gross Margin (2018-2024)
Table 225. Avimex Animal Veterinary Biologics Product and Services
Table 226. Avimex Animal Recent Developments
Table 227. Key Raw Materials Lists
Table 228. Raw Materials Key Suppliers Lists
Table 229. Veterinary Biologics Distributors List
Table 230. Veterinary Biologics Customers List
Table 231. Veterinary Biologics Market Trends
Table 232. Veterinary Biologics Market Drivers
Table 233. Veterinary Biologics Market Challenges
Table 234. Veterinary Biologics Market Restraints
Table 235. Research Programs/Design for This Report
Table 236. Key Data Information from Secondary Sources
Table 237. Key Data Information from Primary Sources
List of Figures
Figure 1. Veterinary Biologics Product Picture
Figure 2. Global Veterinary Biologics Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Veterinary Biologics Market Share by Type in 2022 & 2034
Figure 4. Vaccines Product Picture
Figure 5. Monoclonal Antibodies Product Picture
Figure 6. Global Veterinary Biologics Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 7. Global Veterinary Biologics Market Share by Application in 2022 & 2034
Figure 8. Llivestock
Figure 9. Equine
Figure 10. Other
Figure 11. Veterinary Biologics Report Years Considered
Figure 12. Global Veterinary Biologics Revenue, (US$ Million), 2018 VS 2022 VS 2034
Figure 13. Global Veterinary Biologics Revenue 2018-2034 (US$ Million)
Figure 14. Global Veterinary Biologics Revenue Market Share by Region in Percentage: 2022 Versus 2034
Figure 15. Global Veterinary Biologics Sales Quantity 2018-2034 (K Units)
Figure 16. Global Veterinary Biologics Sales Quantity Market Share by Region (2018-2024)
Figure 17. Global Veterinary Biologics Sales Quantity Market Share by Region (2024-2034)
Figure 18. North America Veterinary Biologics Sales Quantity YoY (2018-2034) & (K Units)
Figure 19. North America Veterinary Biologics Revenue YoY (2018-2034) & (US$ Million)
Figure 20. Europe Veterinary Biologics Sales Quantity YoY (2018-2034) & (K Units)
Figure 21. Europe Veterinary Biologics Revenue YoY (2018-2034) & (US$ Million)
Figure 22. China Veterinary Biologics Sales Quantity YoY (2018-2034) & (K Units)
Figure 23. China Veterinary Biologics Revenue YoY (2018-2034) & (US$ Million)
Figure 24. APAC Veterinary Biologics Sales Quantity YoY (2018-2034) & (K Units)
Figure 25. APAC Veterinary Biologics Revenue YoY (2018-2034) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Veterinary Biologics Sales Quantity YoY (2018-2034) & (K Units)
Figure 27. Middle East, Africa and Latin America Veterinary Biologics Revenue YoY (2018-2034) & (US$ Million)
Figure 28. The Top 10 and Top 5 Players Market Share by Veterinary Biologics Sales Quantity in 2022
Figure 29. The Top 10 and Top 5 Players Market Share by Veterinary Biologics Revenue in 2022
Figure 30. Veterinary Biologics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Veterinary Biologics Sales Quantity Market Share by Type (2018-2034)
Figure 32. Global Veterinary Biologics Revenue Market Share by Type (2018-2034)
Figure 33. Global Veterinary Biologics Sales Quantity Market Share by Application (2018-2034)
Figure 34. Global Veterinary Biologics Revenue Market Share by Application (2018-2034)
Figure 35. North America Veterinary Biologics Revenue Market Share by Company in 2022
Figure 36. North America Veterinary Biologics Sales Quantity Market Share by Company in 2022
Figure 37. North America Veterinary Biologics Sales Quantity Market Share by Type (2018-2034)
Figure 38. North America Veterinary Biologics Revenue Market Share by Type (2018-2034)
Figure 39. North America Veterinary Biologics Sales Quantity Market Share by Application (2018-2034)
Figure 40. North America Veterinary Biologics Revenue Market Share by Application (2018-2034)
Figure 41. North America Veterinary Biologics Revenue Share by Country (2018-2034)
Figure 42. North America Veterinary Biologics Sales Quantity Share by Country (2018-2034)
Figure 43. United States Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 44. Canada Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 45. Europe Veterinary Biologics Sales Quantity Market Share by Company in 2022
Figure 46. Europe Veterinary Biologics Revenue Market Share by Company in 2022
Figure 47. Europe Veterinary Biologics Sales Quantity Market Share by Type (2018-2034)
Figure 48. Europe Veterinary Biologics Revenue Market Share by Type (2018-2034)
Figure 49. Europe Veterinary Biologics Sales Quantity Market Share by Application (2018-2034)
Figure 50. Europe Veterinary Biologics Revenue Market Share by Application (2018-2034)
Figure 51. Europe Veterinary Biologics Revenue Share by Country (2018-2034)
Figure 52. Europe Veterinary Biologics Sales Quantity Share by Country (2018-2034)
Figure 53. Germany Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 54. France Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 55. U.K. Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 56. Italy Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 57. Russia Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 58. China Veterinary Biologics Sales Quantity Market Share by Company in 2022
Figure 59. China Veterinary Biologics Revenue Market Share by Company in 2022
Figure 60. China Veterinary Biologics Sales Quantity Market Share by Type (2018-2034)
Figure 61. China Veterinary Biologics Revenue Market Share by Type (2018-2034)
Figure 62. China Veterinary Biologics Sales Quantity Market Share by Application (2018-2034)
Figure 63. China Veterinary Biologics Revenue Market Share by Application (2018-2034)
Figure 64. APAC Veterinary Biologics Sales Quantity Market Share by Company in 2022
Figure 65. APAC Veterinary Biologics Revenue Market Share by Company in 2022
Figure 66. APAC Veterinary Biologics Sales Quantity Market Share by Type (2018-2034)
Figure 67. APAC Veterinary Biologics Revenue Market Share by Type (2018-2034)
Figure 68. APAC Veterinary Biologics Sales Quantity Market Share by Application (2018-2034)
Figure 69. APAC Veterinary Biologics Revenue Market Share by Application (2018-2034)
Figure 70. APAC Veterinary Biologics Revenue Share by Region (2018-2034)
Figure 71. APAC Veterinary Biologics Sales Quantity Share by Region (2018-2034)
Figure 72. Japan Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 73. South Korea Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 74. China Taiwan Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 75. Southeast Asia Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 76. India Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 77. Middle East, Africa and Latin America Veterinary Biologics Sales Quantity Market Share by Company in 2022
Figure 78. Middle East, Africa and Latin America Veterinary Biologics Revenue Market Share by Company in 2022
Figure 79. Middle East, Africa and Latin America Veterinary Biologics Sales Quantity Market Share by Type (2018-2034)
Figure 80. Middle East, Africa and Latin America Veterinary Biologics Revenue Market Share by Type (2018-2034)
Figure 81. Middle East, Africa and Latin America Veterinary Biologics Sales Quantity Market Share by Application (2018-2034)
Figure 82. Middle East, Africa and Latin America Veterinary Biologics Revenue Market Share by Application (2018-2034)
Figure 83. Middle East, Africa and Latin America Veterinary Biologics Sales Quantity Share by Country (2018-2034)
Figure 84. Middle East, Africa and Latin America Veterinary Biologics Revenue Share by Country (2018-2034)
Figure 85. Brazil Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 86. Mexico Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 87. Turkey Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 88. Israel Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 89. GCC Countries Veterinary Biologics Revenue (2018-2034) & (US$ Million)
Figure 90. Veterinary Biologics Value Chain
Figure 91. Veterinary Biologics Production Process
Figure 92. Channels of Distribution (Direct Vs Distribution)
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed